Rankings
▼
Calendar
SAVA Q2 2023 Earnings — Cassava Sciences, Inc. Revenue & Financial Results | Market Cap Arena
SAVA
Cassava Sciences, Inc.
$116M
Q2 2023 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$0
Gross Profit
-$392,000
Operating Income
-$29M
Net Income
-$26M
EPS (Diluted)
$-0.63
QoQ Revenue Growth
NaN%
Cash Flow
Operating Cash Flow
-$20M
Free Cash Flow
-$20M
Stock-Based Comp.
$835,000
Balance Sheet
Total Assets
$197M
Total Liabilities
$18M
Stockholders' Equity
$179M
Cash & Equivalents
$168M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$0
$0
—
Gross Profit
-$392,000
-$17M
+97.7%
Operating Income
-$29M
-$20M
-44.5%
Net Income
-$26M
-$19M
-36.5%
← FY 2023
All Quarters
Q3 2023 →